Cargando…
Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome
BACKGROUND: Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies, upslanting palpebral fissures, bitemporal alopecia, pigmentary ski...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481077/ https://www.ncbi.nlm.nih.gov/pubmed/26120363 http://dx.doi.org/10.1186/s13039-015-0142-7 |
_version_ | 1782378235580907520 |
---|---|
author | Costa, Larissa Sampaio de Athayde Zandona-Teixeira, Aline C. Montenegro, Marilia M. Dias, Alexandre T. Dutra, Roberta L. Honjo, Rachel S. Bertola, Debora R. Kulikowski, Leslie D. Kim, Chong A. |
author_facet | Costa, Larissa Sampaio de Athayde Zandona-Teixeira, Aline C. Montenegro, Marilia M. Dias, Alexandre T. Dutra, Roberta L. Honjo, Rachel S. Bertola, Debora R. Kulikowski, Leslie D. Kim, Chong A. |
author_sort | Costa, Larissa Sampaio de Athayde |
collection | PubMed |
description | BACKGROUND: Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies, upslanting palpebral fissures, bitemporal alopecia, pigmentary skin anomalies, developmental delay, hypotonia and seizures. Although typical clinical features of PKS commonly exist, clinicians often do not raise the possibility of this diagnosis. RESULTS: We reviewed the medical records of 10 patients with confirmed PKS followed in our service (since 1990 to 2015). Age at diagnosis varied from prenatal to 3 years and clinical features were consistent with those described in the literature. In all patients, peripheral blood karyotypes were normal and cytogenomic study was performed in order to confirm the diagnosis. Three of these patients had PKS diagnosis confirmed by buccal smear MLPA. CONCLUSION: An early conclusion from our results demonstrated that MLPA on buccal smears is a good and non-invasive method to detect extra copies of 12p and should be considered as the first exam, before a skin biopsy for a fibroblast karyotype is performed. |
format | Online Article Text |
id | pubmed-4481077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44810772015-06-27 Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome Costa, Larissa Sampaio de Athayde Zandona-Teixeira, Aline C. Montenegro, Marilia M. Dias, Alexandre T. Dutra, Roberta L. Honjo, Rachel S. Bertola, Debora R. Kulikowski, Leslie D. Kim, Chong A. Mol Cytogenet Research BACKGROUND: Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies, upslanting palpebral fissures, bitemporal alopecia, pigmentary skin anomalies, developmental delay, hypotonia and seizures. Although typical clinical features of PKS commonly exist, clinicians often do not raise the possibility of this diagnosis. RESULTS: We reviewed the medical records of 10 patients with confirmed PKS followed in our service (since 1990 to 2015). Age at diagnosis varied from prenatal to 3 years and clinical features were consistent with those described in the literature. In all patients, peripheral blood karyotypes were normal and cytogenomic study was performed in order to confirm the diagnosis. Three of these patients had PKS diagnosis confirmed by buccal smear MLPA. CONCLUSION: An early conclusion from our results demonstrated that MLPA on buccal smears is a good and non-invasive method to detect extra copies of 12p and should be considered as the first exam, before a skin biopsy for a fibroblast karyotype is performed. BioMed Central 2015-06-26 /pmc/articles/PMC4481077/ /pubmed/26120363 http://dx.doi.org/10.1186/s13039-015-0142-7 Text en © Costa et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Costa, Larissa Sampaio de Athayde Zandona-Teixeira, Aline C. Montenegro, Marilia M. Dias, Alexandre T. Dutra, Roberta L. Honjo, Rachel S. Bertola, Debora R. Kulikowski, Leslie D. Kim, Chong A. Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title | Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title_full | Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title_fullStr | Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title_full_unstemmed | Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title_short | Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome |
title_sort | cytogenomic delineation and clinical follow-up of 10 brazilian patients with pallister-killian syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481077/ https://www.ncbi.nlm.nih.gov/pubmed/26120363 http://dx.doi.org/10.1186/s13039-015-0142-7 |
work_keys_str_mv | AT costalarissasampaiodeathayde cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT zandonateixeiraalinec cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT montenegromariliam cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT diasalexandret cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT dutrarobertal cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT honjorachels cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT bertoladeborar cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT kulikowskileslied cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome AT kimchonga cytogenomicdelineationandclinicalfollowupof10brazilianpatientswithpallisterkilliansyndrome |